CAAT Europe Information Day on Biology-inspired Microphysiological Systems
The Information day on Biology-inspired Microphysiological Systems (MPS) to advance Medicines for Patients Benefit will host key international experts from academia, regulatory agencies, and industry.
Among them is hDMT managing director Janny van den Eijnden - van Raaij talking about hDMT and Organ-on-Chip networking in Europe.
Microfluidic microphysiological systems (also referred to as tissues-on-a-chip, organ-on-a-chip, multi-organ-chip, human-on-a-chip, body-on-a-chip or patient-on-a-chip tools) are considered an enabling technology for the development of approaches to reliably predict the safety and efficacy of novel drug candidates prior to their use in humans. A transatlantic toxicology think tank involving academia, industries and regulatory bodies from all over the world reviewed the status quo of MPS in June 2015 in Berlin (Marx et al 2016, ALTEX 33, 272-321). Now, four years later stakeholders meet again in Berlin to update the review and to state the roadmap towards the reduction and replacement of animals by MPS tools for the benefit of patients more precisely.
About CAAT Europe
The Center for Alternative to Animal Testing in Europe (CAAT-Europe), housed at the University of Konstanz, coordinates transatlantic activities to promote the development of new and improved methods in toxicology, to be a partner in strategy development, to provide platforms for different stakeholders, to exchange ideas, and to support the 3R's principle of humane science in different ways.